FirstCry-Backed Swara Baby Eyes Rs. 1,000 Crore IPO, Should Investors Watch This Babycare Startup?

FirstCry-backed Swara Baby Products is reportedly preparing to file draft IPO papers with SEBI in June 2026 for a public issue of up to Rs. 1,000 crore. The company is part of Brainbees Solutions, the listed parent of FirstCry, and works in the baby and hygiene products space. This is an interesting IPO story because Swara Baby is not a flashy app or a quick commerce platform. It is a manufacturing-led consumer business focused on products like diapers and hygiene items. That makes the investment question different.

For investors, the main question is simple. Can a FirstCry-linked hygiene products company build enough scale, margins and brand strength to justify a public listing?

What Swara Baby does

Swara Baby Products manufactures and trades baby diapers and other hygiene-related products. Reports say the company started as a single-product operating business in 2021 and has now expanded into seven categories. These categories include baby tape-style diapers, baby pant-style diapers, adult tape-style diapers, adult pant-style diapers, sanitary napkins and panty liners.

This is a practical market. Parents buy diapers regularly, not once in a while. If a product works well, families may repeat purchases every month. That makes the category attractive because demand can be steady.

Swara Baby is also connected with FirstCry’s larger ecosystem. FirstCry already sells baby and kids products through its online platform, mobile app, stores and private labels. This gives Swara Baby a strong parent network in a category where distribution matters.

FirstCry connection and company background

Swara Baby is controlled by Brainbees Solutions, the company behind FirstCry. As per the reports, Brainbees owns 76.59 percent in Swara Baby.

FirstCry was founded in 2010 by Supam Maheshwari and Amitava Saha. It became one of India’s best-known baby and kids retail platforms and later listed on the stock exchanges in 2024.

Swara Baby Products was incorporated in India on November 23, 2016, according to FirstCry’s exchange disclosure. The company’s hygiene business has also been reorganized recently, with Solis Hygiene becoming part of the Swara Baby structure.

This background matters because Swara Baby is not entering the market alone. It sits inside a larger babycare ecosystem with an existing consumer base, supply chain and retail reach.

Inside the proposed IPO

Reports say Swara Baby may file its draft red herring prospectus with SEBI by the end of June 2026. The proposed IPO size is expected to be up to Rs. 1,000 crore, while the fundraising plan at around $100 million.

The issue is expected to include fresh shares and an offer for sale. Fresh issue proceeds go to the company, while offer-for-sale proceeds go to existing shareholders selling their shares. JM Financial and Avendus Capital have reportedly been appointed to manage the issue.

Since the DRHP is not filed yet, investors should wait for official details and also remember that this is not an investment advice. The final issue size, fresh issue portion, OFS size, valuation, financials and risk factors will become clearer only after the documents are available.

Why this IPO could attract attention

The babycare and hygiene market has strong repeat demand. Diapers, sanitary products and adult hygiene products are not luxury items for many households. They are routine-use products. India also has rising awareness around hygiene, convenience and organized babycare brands. Urban parents often prefer trusted brands, reliable sizing and consistent quality. E-commerce has also made repeat purchase easier.

A simple example explains the opportunity. A family with a newborn may buy diapers several times a month. If the brand is comfortable, leak-proof and reasonably priced, the family may keep buying it for years. That repeat behaviour can help companies build predictable revenue.

Swara Baby may also benefit from FirstCry’s strong parent brand. FirstCry already has customer trust in baby products, which can support related manufacturing and private-label categories.

Competitors in the hygiene market

Swara Baby will compete in a tough market. Baby diapers and hygiene products already have strong national and global brands. Its competitors include Pampers from P&G, MamyPoko from Unicharm, Huggies from Kimberly-Clark, Himalaya BabyCare, Nobel Hygiene, Teddyy, Friends Adult Diapers and several private-label and regional brands.

Competition will happen on price, comfort, absorbency, skin safety, distribution and brand trust. In baby products, parents do not easily experiment if they are happy with one product.

This means Swara Baby must prove that it can offer quality at scale while keeping pricing competitive.

Are these startups worth for IPO

The better question is not whether Swara Baby is automatically “worth it,” but whether its IPO valuation matches its business quality. Investors should study five things when the DRHP comes out.

1. First, revenue growth. Is Swara Baby growing because of real customer demand or only because of related-party sales through FirstCry?
2. Second, margins. Manufacturing hygiene products can be competitive. Raw material costs, packaging and distribution can affect profitability.
3. Third, customer concentration. If too much business depends on FirstCry or one major channel, that can be a risk.
4. Fourth, brand strength. Does Swara Baby sell mainly as a contract manufacturer, private-label supplier or independent brand owner? Brand ownership can change long-term value.
5. Fifth, use of IPO money. If fresh funds are used for capacity expansion, debt reduction or working capital, investors should check whether those plans are sensible.

Why the FirstCry link helps and also needs scrutiny

FirstCry’s backing is a clear advantage. It gives Swara Baby access to a strong babycare ecosystem, market knowledge and distribution support. But investors should also study related-party transactions carefully. If Swara Baby sells products to FirstCry-linked entities, the pricing and dependency must be transparent.

This is normal for group companies, but public investors need clarity. The IPO documents should explain how much revenue comes from group channels and how much comes from outside customers.

Possible risks for investors

Swara Baby works in a category where quality issues can quickly hurt trust. Diapers and hygiene products are used on babies, adults and sensitive users. Comfort, leakage protection and skin safety matter deeply.

The business may also face input cost pressure. Materials used in diapers and sanitary products can become expensive, which may reduce margins if the company cannot pass the cost to customers.

Another risk is pricing competition. Big brands may offer discounts, while smaller brands may compete aggressively online. Swara Baby will need a clear positioning.

Conclusion with key takeaways

Swara Baby’s planned IPO could bring another FirstCry-linked business to the public market. The company operates in a large and practical category, but investors should wait for the DRHP before forming a final view.

Key takeaways

• Swara Baby Products is reportedly planning to file IPO papers in June 2026 for up to Rs. 1,000 crore.
• The company is backed by FirstCry parent Brainbees Solutions, which owns 76.59 percent in Swara Baby.
• Swara Baby manufactures and trades diapers and hygiene-related products.
• The company competes with Pampers, MamyPoko, Huggies, Himalaya BabyCare, Nobel Hygiene and other hygiene brands.

Investors should study valuation, margins, related-party sales, growth and use of IPO proceeds before deciding.

Facts Input- Upstox